Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alternative Treatment”

741 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 741 results

Testing effectiveness (Phase 2)Looking for participantsNCT06383533
What this trial is testing

Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma

Who this might be right for
Bile Duct Adenocarcinoma Non-ResectableHER2 Gene Mutation
Zhejiang Cancer Hospital 28
Not applicableStudy completedNCT01790958
What this trial is testing

Microcurrent Stimulation to Treat Macular Degeneration

Who this might be right for
Retinal DiseasesStargardt's DiseaseRetinitis Pigmentosa
Retina Institute of Hawaii 50
Post-approval studies (Phase 4)UnknownNCT05200793
What this trial is testing

Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome (PCOS)
Alexandria University 75
Not applicableWithdrawnNCT04709757
What this trial is testing

Comparison of Continuous and Burst High Frequency Spinal Cord Stimulation Paradigms

Who this might be right for
Chronic Low-back PainCRPSPeripheral Neuropathy
Rush University Medical Center
Not applicableStudy completedNCT01799733
What this trial is testing

Alternative Treatments for Premenstrual Dysphoric Disorder

Who this might be right for
Premenstrual Dysphoric Disorder
University of California, San Diego 43
Not applicableStudy completedNCT01349387
What this trial is testing

Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing

Who this might be right for
Type 2 Diabetes
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète 25
Large-scale testing (Phase 3)Study completedNCT02965378
What this trial is testing

Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Who this might be right for
FGFR1 Gene AmplificationFGFR1 Gene MutationFGFR2 Gene Amplification+5 more
SWOG Cancer Research Network 43
Testing effectiveness (Phase 2)Study completedNCT00000233
What this trial is testing

Alternate Day Buprenorphine Administration, Phase X - 15

Who this might be right for
Opioid-Related Disorders
National Institute on Drug Abuse (NIDA)
Not applicableStudy completedNCT01097538
What this trial is testing

Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Hicks, Audrey, Ph.D. 10
Large-scale testing (Phase 3)Study completedNCT00351923
What this trial is testing

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

Who this might be right for
MeaslesMumpsRubella+1 more
GlaxoSmithKline 330
Early research (Phase 1)Study completedNCT03084640
What this trial is testing

Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Regeneron Pharmaceuticals 30
Not applicableUnknownNCT05314296
What this trial is testing

Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy

Who this might be right for
Non Small Cell Lung CancerT790MEGFR Gene Mutation
N.N. Blokhin National Medical Research Center of Oncology 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06509997
What this trial is testing

A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Lei Liu 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04238624
What this trial is testing

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerThyroid CancerBRAF Gene Mutation+1 more
Memorial Sloan Kettering Cancer Center 16
Not applicableNo Longer AvailableNCT01260779
What this trial is testing

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

Who this might be right for
Cutaneous or Subcutaneous Tumors Where There is no Comparable or SatisfactoryApproved Alternative Therapy
Provectus Biopharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT02598557
What this trial is testing

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

Who this might be right for
Stage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
National Cancer Institute (NCI) 180
Not applicableNot Yet RecruitingNCT06063421
What this trial is testing

Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in Pakistan

Who this might be right for
Smoking CessationElectronic Cigarette Use
Strategic Health Research Limited 438
Not applicableStudy completedNCT01596608
What this trial is testing

Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder

Who this might be right for
Depressive DisorderSchizophreniaSchizoaffective Disorder+1 more
Centre for Addiction and Mental Health 224
Testing effectiveness (Phase 2)Looking for participantsNCT07007949
What this trial is testing

A New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaIDH1 Gene MutationIvosidenib
The First Affiliated Hospital of Soochow University 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT07197268
What this trial is testing

Personalized Antisense Oligonucleotide Therapy for A Single Participant With ASXL3 Gene Mutation

Who this might be right for
Bainbridge-Ropers Syndrome
n-Lorem Foundation 1
Load More Results